Float Short %

0.67

Margin Of Safety %

Put/Call OI Ratio

0.4

EPS Next Q Diff

-0.48

EPS Last/This Y

EPS This/Next Y

0.45

Price

37.56

Target Price

43.35

Analyst Recom

Performance Q

-3.07

Relative Volume

0.68

Beta

0.51

Ticker: GSK

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	GSK	38.18	0.92	0.99	152549
2025-07-07	GSK	38.21	0.92	8.42	151820
2025-07-08	GSK	38.48	0.96	0.24	154847
2025-07-09	GSK	39.05	0.91	0.08	160973
2025-07-10	GSK	39.57	0.85	0.41	167094
2025-07-11	GSK	38.28	0.82	2.91	177812
2025-07-14	GSK	38.3	0.77	2.55	175714
2025-07-15	GSK	37.82	0.83	2.01	187921
2025-07-16	GSK	38.29	0.84	2.70	188363
2025-07-17	GSK	36.5	0.82	4.11	190125
2025-07-18	GSK	36.32	0.86	1.56	197359
2025-07-21	GSK	36.22	0.48	0.30	137864
2025-07-22	GSK	36.99	0.48	1.77	140102
2025-07-23	GSK	38.05	0.56	0.18	155063
2025-07-24	GSK	38.22	0.53	3.52	161760
2025-07-25	GSK	37.97	0.52	0.55	161380
2025-07-28	GSK	37.43	0.42	1.09	135497
2025-07-29	GSK	37.68	0.42	0.22	136207
2025-07-30	GSK	39	0.41	0.15	148593
2025-07-31	GSK	37.15	0.40	1.19	152132
2025-08-01	GSK	37.56	0.40	0.18	152585
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	GSK	38.18	1.9	6199.2	4.38
2025-07-07	GSK	38.20	1.9	6293.6	4.38
2025-07-08	GSK	38.48	1.9	6235.5	4.38
2025-07-09	GSK	39.04	1.9	6099.6	4.38
2025-07-10	GSK	39.58	1.9	6120.2	4.38
2025-07-11	GSK	38.28	1.9	5687.5	4.38
2025-07-14	GSK	38.30	1.9	6036.5	4.38
2025-07-15	GSK	37.82	1.9	5729.7	4.38
2025-07-16	GSK	38.28	1.9	6221.4	4.38
2025-07-17	GSK	36.47	1.9	5272.9	4.38
2025-07-18	GSK	36.31	1.9	5860.9	4.38
2025-07-21	GSK	36.22	1.9	6313.6	4.38
2025-07-22	GSK	37.00	1.9	6112.6	4.38
2025-07-23	GSK	38.03	1.9	6110.4	4.38
2025-07-24	GSK	38.23	1.9	5810.3	4.38
2025-07-25	GSK	37.97	1.9	5896.1	4.38
2025-07-28	GSK	37.46	-0.4	5612.0	4.26
2025-07-29	GSK	37.67	-0.4	5904.3	4.26
2025-07-30	GSK	38.97	-0.4	6241.3	4.26
2025-07-31	GSK	37.15	-15.4	4911.9	4.29
2025-08-01	GSK	37.56	-15.4	5434.0	4.29
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	GSK	0	-5.43	0.81
2025-07-07	GSK	0	-5.40	0.81
2025-07-08	GSK	0	-5.40	0.81
2025-07-09	GSK	0	-5.40	0.81
2025-07-10	GSK	0	-5.40	0.81
2025-07-11	GSK	0	-5.40	0.92
2025-07-14	GSK	0	-5.41	0.92
2025-07-15	GSK	0	-5.41	0.92
2025-07-16	GSK	0	-5.41	0.92
2025-07-17	GSK	0	-5.41	0.92
2025-07-18	GSK	0	-5.41	0.92
2025-07-21	GSK	0	-6.59	0.92
2025-07-22	GSK	0	-6.59	0.92
2025-07-23	GSK	0	-6.59	0.92
2025-07-24	GSK	0	-6.59	0.92
2025-07-25	GSK	0	-6.59	0.67
2025-07-28	GSK	0	-6.48	0.67
2025-07-29	GSK	0	-6.48	0.67
2025-07-30	GSK	0	-6.48	0.67
2025-07-31	GSK	0	-6.48	0.67
2025-08-01	GSK	0	-6.48	0.67
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.23

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

0.75

Insider Transactions

Institutional Transactions

-6.48

Beta

0.51

Average Sales Estimate Current Quarter

8112

Average Sales Estimate Next Quarter

7848

Fair Value

49.49

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

22.2

Max Drawdown 5-Year %

-39.3

Target Price

43.35

P/E

17.5

Forward P/E

7.73

PEG

1.8

P/S

1.85

P/B

3.75

P/Free Cash Flow

9.8

EPS

2.15

Average EPS Est. Cur. Y

4.29

EPS Next Y. (Est.)

4.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.81

Relative Volume

0.68

Return on Equity vs Sector %

-0.6

Return on Equity vs Industry %

-8.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.1

EBIT Estimation

5434

GSK plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 68629

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.

stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today

news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025

marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance

stock history GSK – GlaxoSmithKline plc invest stock market

stock prices GSK premarket after hours

ticker GSK fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: GSK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y